Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Taussky

Showing results (31-40 of 118) with videos related to

Pageof 12
Sort By:
Brachytherapy|February 15, 2011
Combined intensity-modulated radiation therapy vs. three-dimensional highly conformal radiotherapy after (125)I prostate permanent seed brachytherapy: a comparative treatment planning studyThomas Zilli, Chantal Boudreau, Edith J Filion, et al.
Brachytherapy|December 16, 2019
Favorable preservation of erectile function after prostate brachytherapy for localized prostate cancerAmélie Bazinet, Kevin C Zorn, Daniel Taussky, et al.
BJU International|November 27, 2013
The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low-dose rate (LDR) brachytherapyVimal Krishnan, Guila Delouya, Jean-Paul Bahary, et al.
Radiation Oncology (London, England)|July 11, 2013
Prostate volume changes during permanent seed brachytherapy: an analysis of intra-operative variations, predictive factors and clinical implicationCiprian Chira, Guila Delouya, Sandra Larrivée, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 24, 2020
Active surveillance before radiotherapy: Outcome and predictive factors for multiple biopsies before treatmentAlexandre Alcaidinho, Guila Delouya, Jean-Paul Bahary, et al.
Urology|August 30, 2014
Analysis of the Cancer of the Prostate Risk Assessment to predict for biochemical failure after external beam radiotherapy or prostate seed brachytherapyGuila Delouya, Vimal Krishnan, Jean-Paul Bahary, et al.
Brachytherapy|August 30, 2018
Risk factors for biochemical recurrence after a tissue-ablative prostate-specific antigen <0.2 ng/mLDaniel Taussky, Carole Lambert, Nissan Meissner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2010
Migration of intraprostatic fiducial markers and its influence on the matching quality in external beam radiation therapy for prostate cancerGuila Delouya, Jean-François Carrier, Dominic Béliveau-Nadeau, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2015
Radiation therapy after radical prostatectomy: A single-centre radiation oncology experience in trends of referral and treatment practicesMichel Zimmermann, Daniel Taussky, Guila Delouya, et al.
Hormone Molecular Biology and Clinical Investigation|March 5, 2016
Impact of visceral fat volume and fat density on biochemical outcome after radical prostatectomy and postoperative radiotherapyMichel Zimmermann, Guila Delouya, Maroie Barkati, et al.
Pageof 12

Showing results (31-40 of 118) with videos related to

Sort By:
Pageof 12
Brachytherapy|February 15, 2011
Combined intensity-modulated radiation therapy vs. three-dimensional highly conformal radiotherapy after (125)I prostate permanent seed brachytherapy: a comparative treatment planning studyThomas Zilli, Chantal Boudreau, Edith J Filion, et al.
Brachytherapy|December 16, 2019
Favorable preservation of erectile function after prostate brachytherapy for localized prostate cancerAmélie Bazinet, Kevin C Zorn, Daniel Taussky, et al.
BJU International|November 27, 2013
The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low-dose rate (LDR) brachytherapyVimal Krishnan, Guila Delouya, Jean-Paul Bahary, et al.
Radiation Oncology (London, England)|July 11, 2013
Prostate volume changes during permanent seed brachytherapy: an analysis of intra-operative variations, predictive factors and clinical implicationCiprian Chira, Guila Delouya, Sandra Larrivée, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 24, 2020
Active surveillance before radiotherapy: Outcome and predictive factors for multiple biopsies before treatmentAlexandre Alcaidinho, Guila Delouya, Jean-Paul Bahary, et al.
Urology|August 30, 2014
Analysis of the Cancer of the Prostate Risk Assessment to predict for biochemical failure after external beam radiotherapy or prostate seed brachytherapyGuila Delouya, Vimal Krishnan, Jean-Paul Bahary, et al.
Brachytherapy|August 30, 2018
Risk factors for biochemical recurrence after a tissue-ablative prostate-specific antigen <0.2 ng/mLDaniel Taussky, Carole Lambert, Nissan Meissner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2010
Migration of intraprostatic fiducial markers and its influence on the matching quality in external beam radiation therapy for prostate cancerGuila Delouya, Jean-François Carrier, Dominic Béliveau-Nadeau, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2015
Radiation therapy after radical prostatectomy: A single-centre radiation oncology experience in trends of referral and treatment practicesMichel Zimmermann, Daniel Taussky, Guila Delouya, et al.
Hormone Molecular Biology and Clinical Investigation|March 5, 2016
Impact of visceral fat volume and fat density on biochemical outcome after radical prostatectomy and postoperative radiotherapyMichel Zimmermann, Guila Delouya, Maroie Barkati, et al.
Pageof 12